Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Trandolapril

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,920Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CCSB accomplished Caspofungin and Trandolapril remote audit.
    CCSB accomplished Caspofungin and Trandolapril remote audit.

    10 May 2022

    // PRESS RELEASE

    http://www.ccsb.com.tw/english/04_news/02_detail.aspx?pid=1&xid=101

    PRESS RELEASE
    10 May 2022
    Share Share
    JGL celebrates the launch of Magnolicomb HCT
    JGL celebrates the launch of Magnolicomb HCT

    23 Oct 2019

    // PRESS RELEASE

    https://www.jgl.hr/en/jgl-celebrates-the-launch-of-magnolicomb-hct

    PRESS RELEASE
    23 Oct 2019
    Share Share
    Glenmark's Generic Trandolapril & Verapamil Hydrochloride (1mg/240mg, 2mg/180mg, 2mg/240mg and 4mg/240mg) Approved in USA for Hypertension
    Glenmark's Generic Trandolapril & Verapamil Hydrochloride (1mg/240mg, 2mg/180mg, 2mg/240mg and 4mg/240mg) Approved in USA for Hypertension

    26 Feb 2015

    // Press Release Glenmark

    http://www.glenmarkpharma.com/GLN_NWS/PDF/Glenmark_announces_approval_and_launch_of_Trandolapril_and_Verapamil_Hydrochloride_HCl_Extended_Release_Tablets_in_the_US.pdf

    Press Release Glenmark
    26 Feb 2015
    Share Share